Position in NVO
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$41,707
-$136,898 QoQ
Shares Held
870
-82.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,132
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Tradewinds Capital Management, LLC holds $4,218,548 across 12 Drug Manufacturers - General names. NVO ranks #7 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
11,273 | $2,863,003 | |
| 2 | ABBV |
AbbVie Inc.
|
3,020 | $759,952 | |
| 3 | LLY |
ELI LILLY & Co
|
261 | $313,051 | |
| 4 | AMGN |
Amgen Inc
|
205 | $74,234 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
1,232 | $70,987 | |
| 6 | PFE |
Pfizer Inc
|
1,976 | $47,582 | |
| 7 | NVO |
Novo Nordisk A S
This page
|
870 | $41,707 | |
| 8 | MRK |
Merck & Co., Inc.
|
224 | $28,784 |
All Filings in NVO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $41,707 | 870 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $178,605 | 4,860 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $247,276 | 4,860 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $269,681 | 4,860 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $335,437 | 4,860 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $337,478 | 4,860 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $428,723 | 4,984 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $578,680 | 4,860 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $693,716 | 4,860 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $649,062 | 5,055 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $512,594 | 4,955 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $441,968 | 4,860 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $393,246 | 2,430 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $386,710 | 2,430 | Shares | Sole | 2023-04-10 | |
| 2022-12-31 | $328,876 | 2,430 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $242,100 | 2,430 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $47,914 | 430 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $53,859 | 485 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $54,320 | 485 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $46,564 | 485 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $40,628 | 485 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $32,698 | 485 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $33,877 | 485 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $33,673 | 485 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $31,757 | 485 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $29,197 | 485 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||